New genetic evidence suggests that people with an inherited tendency towards blood clots may be at higher risk of developing ...

For men with hemophilia B, receipt of gene therapy comprising an infusion of etranacogene dezaparvovec results in sustained endogenous factor IX expression and low annualized bleeding rates over five ...

Hemophilia A and B are similar conditions that affect the blood’s ability to clot. They typically occur due to gene variations that affect different blood clotting factors. Hemophilia is a group of ...

Blood clots can form in both arteries and veins. However, the reasons behind them differ, as do the consequences and the chances of preventing blood clots. In Sweden, almost half of all cases of ...

The era of genetic medicines has ushered in novel and exciting ways of treating genetic diseases, one of which includes bringing to reality the promise of a one-time treatment by addressing the root ...

March 7 (Reuters) - Scientists have pinpointed 16 new genetic variants in people who developed severe COVID-19 in a large study published on Monday that could help researchers develop treatments for ...

Hemophilia arises due to the deficiency or malfunction of plasma coagulation factor VIII or factor IX. [iStockphoto] Haemophilia, a rare genetic blood disorder primarily affecting males, is a ...

Hemophilia B, also known as Christmas disease, is a bleeding disorder. Its characteristic feature is a deficiency of clotting factor IX. This is a protein present in the blood that helps with ...

Every time Tabitha publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...

The discovery of an unknown organelle inside our cells could open the door to new treatments for devastating inherited diseases. The organelle, a type of specialized structure, has been dubbed a ...